These 96-well plates are pre-configured with the most appropriate TaqMan® Gene Expression Assays for a specific biological process, pathway, or disease state. Each plate contains predefined assays and endogenous controls dried-down in the wells, ready for accurate assessment of an entire gene signature in one simple experiment. The panel of assays in the TaqMan® Array 96-well Human Apoptosis Plate targets genes from both of the signaling pathways that initiate mammalian apoptosis, the death receptor regulated pathway and the BCL-2 family pathway. Genes such as capases which are involved in the final mechanisms of both cell death pathways are also present in the panel.